Clinical Trial Update: Safety and Efficacy of Two Different Concentrations (0.5% and 1%) of Progesterone Topical Gel Compared to Placebo in Patients Diagnosed With Moderate to Severe Dry Eye Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of two concentrations (0.5% and 1%) of progesterone topical gel versus placebo in moderate to severe dry eye syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Progesterone topical gel (progesterone topical gel)

Snippet

Sponsor: SIFI SpA | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED